Figure 1.

Noninvasive imaging in ACE was not complicated by the putative immunoprivilege and enabled visualization of the interaction between CD4+ Teff cells and their target cells. (A–D) The efficacies of β cell antigen–specific CD4+ Teff and Treg cells in the endogenous pancreatic islet were compared with that of islet grafts in the anterior chamber of the eye (ACE). (A) For immune responses in native pancreata, NOD.SCID mice were injected with either BDC2.5 Teff cells or Treg–Teff mixture. Damage to pancreatic islets was monitored by reading blood glucose (BG) levels. Animals with consecutive readings of BG > 250 mg/deciliter were considered diabetic, or failed Treg cell protection if Treg cells were co-transferred with Teff cells. For immune responses in ACE grafts, NOD.SCID mice were rendered diabetic through streptozotocin destruction of pancreatic β cells, and then transplanted with pancreatic islets from allogeneic (B6) or syngeneic (NOD.SCID) donors into ACE. After stable engraftment (>2 wk after transplantation), CD4+ Teff cells alone (B) or Treg–Teff mixture (C) was injected into the graft-bearing mice. Graft damage was monitored by BG readings. (D) Summary of results in A–C. The cumulative incidence of diabetes was calculated for the groups of animals (n = 4–26; 2–3 experiments) presented individually in A–C. (E) 3D rendering of in vivo fluorescence micrographs for apoptotic signal Annexin V in areas of CD4+ BDC2.5 Teff cells engaging in direct contact with β cell targets. The results represent two experiments with a total of 4 mice analyzed with snapshot imaging of 1–3 islets per animal. Bar, 100 µm. See Video 1.

or Create an Account

Close Modal
Close Modal